161 related articles for article (PubMed ID: 12387057)
1. [Aminoguanidine and other AGE inhibitors].
Kawakami M; Kuroki M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():601-5. PubMed ID: 12387057
[No Abstract] [Full Text] [Related]
2. [Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Ishikawa N; Miyata T; Kurokawa K
Nihon Rinsho; 2004 May; 62 Suppl 5():389-92. PubMed ID: 15197951
[No Abstract] [Full Text] [Related]
3. [OPB-9195].
Takeuchi M; Yamagishi S; Makita Z
Nihon Rinsho; 2002 Sep; 60 Suppl 9():606-10. PubMed ID: 12387058
[No Abstract] [Full Text] [Related]
4. Aldose reductase inhibitors and diabetic complications.
Raskin P; Rosenstock J
Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
[No Abstract] [Full Text] [Related]
5. [Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
Yamagishi S; Imaizumi T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():136-8. PubMed ID: 15999696
[No Abstract] [Full Text] [Related]
6. [Current advances in the treatment of diabetes mellitus].
Ohta M
Nihon Ika Daigaku Zasshi; 1999 Jun; 66(3):195-8. PubMed ID: 10401238
[No Abstract] [Full Text] [Related]
7. [Antioxidant and anti-AGE therapeutics: evaluation and perspectives].
Bonnefont-Rousselot D
J Soc Biol; 2001; 195(4):391-8. PubMed ID: 11938556
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of diabetic complications.
Altan VM
Curr Med Chem; 2003 Aug; 10(15):1317-27. PubMed ID: 12871132
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products and diabetic complications.
Stitt AW; Jenkins AJ; Cooper ME
Expert Opin Investig Drugs; 2002 Sep; 11(9):1205-23. PubMed ID: 12225243
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies.
Jandeleit-Dahm KA; Lassila M; Allen TJ
Ann N Y Acad Sci; 2005 Jun; 1043():759-66. PubMed ID: 16037303
[TBL] [Abstract][Full Text] [Related]
11. Pimagedine: a novel therapy for diabetic nephropathy.
Abdel-Rahman E; Bolton WK
Expert Opin Investig Drugs; 2002 Apr; 11(4):565-74. PubMed ID: 11922864
[TBL] [Abstract][Full Text] [Related]
12. Clinical potential of advanced glycation end-product inhibitors in diabetes mellitus.
Menè P; Festuccia F; Pugliese F
Am J Cardiovasc Drugs; 2003; 3(5):315-20. PubMed ID: 14728065
[TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
[TBL] [Abstract][Full Text] [Related]
14. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
Boel E; Selmer J; Flodgaard HJ; Jensen T
J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
Vasan S; Foiles P; Founds H
Arch Biochem Biophys; 2003 Nov; 419(1):89-96. PubMed ID: 14568012
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
Silacci P
J Hypertens; 2002 Aug; 20(8):1483-5. PubMed ID: 12172306
[No Abstract] [Full Text] [Related]
17. [Disorders of the cardiovascular system in patients with diabetes mellitus].
Kliachko VR; Mazovetskiĭ AG; Slavina LS
Kardiologiia; 1974 Oct; 14(10):150-8. PubMed ID: 4280467
[No Abstract] [Full Text] [Related]
18. Potential new therapeutic agents for diabetic kidney disease.
Turgut F; Bolton WK
Am J Kidney Dis; 2010 May; 55(5):928-40. PubMed ID: 20138415
[TBL] [Abstract][Full Text] [Related]
19. Alternative therapeutic principles in the prevention of microvascular and neuropathic complications.
Gries FA
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S201-7. PubMed ID: 8529515
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
Forbes JM; Yee LT; Thallas V; Lassila M; Candido R; Jandeleit-Dahm KA; Thomas MC; Burns WC; Deemer EK; Thorpe SR; Cooper ME; Allen TJ
Diabetes; 2004 Jul; 53(7):1813-23. PubMed ID: 15220206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
